Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67591193
Model No.: CAS:439081-18-2
Brand: DM
Packaging: Double PE with aluminium foil bag
Productivity: 100kgs/month
Transportation: Ocean,Air
Place of Origin: Hebei,China
Supply Ability: 100KGS/MONTH
Certificate: ISO9001
Port: SHANGHAI
Payment Type: L/C,T/T,Paypal
Incoterm: FOB,CIF
Product name: Afatinib (BIBW 2992)
Cas Number: 439081-18-2
Moculer formula: C24H25ClFN5O3
Moculer weigh: 485.944
Certification of 439081-18-2
Appearance | White to off-white powder | Complies |
Identification | H-NMR | Complies |
Purity(by HPLC) | Not less than 99.0% | 99.47% |
Loss on dry | Not more than 0.5% | 0.25% |
Single impurity | Not more than 1.0% | 0.32% |
Conclusion | The batch complies with In-house standard.
|
More information of 439081-18-2
It is a small molecule tyrosine kinase inhibitor. It has been shown to significantly inhibit growth of breast cancer in animal (xenograft) modelsand has shown partial responses in clinical trials with renal cell carcinoma (RCC) and several other tumour types.
Application of 439081-18-2
It was approved for RCC by the U.S. Food and Drug Administration after showing a modest increase in progression-free survival.
We are the professional manufacturer of API,Raw Material Pharma,Pharmaceutical Intermediates,Active Pharmaceutical Ingredients ,Agrochemical Intermediates and Fine Chemicals.with best quality and competitive price.
Product Categories : APIs And Intermediates > APIs Powder
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.